- Home
- MATH vs XCUR Comparison
MATH vs XCUR Comparison
Compare MATH & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATH
- XCUR
- Stock Information
- Founded
- MATH 2015
- XCUR 2011
- Country
- MATH Hong Kong
- XCUR United States
- Employees
- MATH N/A
- XCUR N/A
- Industry
- MATH Finance/Investors Services
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- MATH Finance
- XCUR Health Care
- Exchange
- MATH Nasdaq
- XCUR Nasdaq
- Market Cap
- MATH 44.7M
- XCUR 39.9M
- IPO Year
- MATH N/A
- XCUR N/A
- Fundamental
- Price
- MATH $1.03
- XCUR $17.97
- Analyst Decision
- MATH
- XCUR
- Analyst Count
- MATH 0
- XCUR 0
- Target Price
- MATH N/A
- XCUR N/A
- AVG Volume (30 Days)
- MATH 64.4K
- XCUR 1.9M
- Earning Date
- MATH 02-12-2025
- XCUR 11-14-2024
- Dividend Yield
- MATH N/A
- XCUR N/A
- EPS Growth
- MATH N/A
- XCUR N/A
- EPS
- MATH N/A
- XCUR N/A
- Revenue
- MATH $16,763,545.00
- XCUR $500,000.00
- Revenue This Year
- MATH N/A
- XCUR N/A
- Revenue Next Year
- MATH N/A
- XCUR N/A
- P/E Ratio
- MATH N/A
- XCUR N/A
- Revenue Growth
- MATH 194.51
- XCUR N/A
- 52 Week Low
- MATH $0.80
- XCUR $1.44
- 52 Week High
- MATH $2.27
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- MATH 47.64
- XCUR 53.17
- Support Level
- MATH $0.99
- XCUR $17.12
- Resistance Level
- MATH $1.06
- XCUR $19.22
- Average True Range (ATR)
- MATH 0.07
- XCUR 4.35
- MACD
- MATH 0.02
- XCUR -1.06
- Stochastic Oscillator
- MATH 60.98
- XCUR 22.48
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is to enable the transition towards digital asset technology. The company aims to provide a crypto derivatives product services for users world-wide. The company has three operating segments. The Longyun operating segment reflects the Company's crowdfunding and incubation business. The Dacheng Liantong operating segment reflects the Company's business of platform services. The Metalpha operating segment reflects the Company's business of proprietary trading of digital assets. The Company is generates its revenue from Hong Kong.
About XCUR Exicure Inc.
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.